Citadel Advisors »

Predictive Oncology shares owned by Citadel Advisors

Quarter-by-quarter ownership of Predictive Oncology (AGPU) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Predictive Oncology

Tip: Access up to 7 years of quarterly data

All positions including Predictive Oncology held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Predictive Oncology by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2026-06-30 $103k 14k 7.58

More positions owned by Citadel Advisors

State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Micron Technology Call Option (MU)
Tesla Motors Call Option (TSLA)
NVIDIA Corporation Call Option (NVDA)
Sandisk Corp (SNDK)
Advanced Micro Devices Call Option (AMD)
Microsoft Corporation Call Option (MSFT)
Apple Call Option (AAPL)
Vaneck Etf Trust Semiconductr Etf Call Option (SMH)
Meta Platforms Cl A (META)
Ishares Tr Core S&p500 Etf (IVV)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Amazon (AMZN)

View all positions for Citadel Advisors

Top funds holding Predictive Oncology

Jane Street
Diametric Capital
Vanguard Capital Management
Geode Capital Management
Vanguard Fiduciary Trust
XTX Topco
BlackRock
Citadel Advisors
Alpine Partners VI
Persistent Asset Partners
UBS Group
Wells Fargo & Company
Tower Research Capital
Bnp Paribas Arbitrage, Snc
Carnegie Mellon University

View all funds holding Predictive Oncology